DoD tests AI models that make it easy to switch from vendors like Palantir
Chimera Investment Corporation (NYSE:CIM), a $1.13 billion market cap company currently trading at $13.89, reported the outcomes of its 2025 annual meeting of stockholders, which took place on June 10, 2025. According to InvestingPro analysis, the company maintains a "GOOD" financial health score and appears undervalued based on its Fair Value assessment. The meeting focused on the election of directors, advisory votes on executive compensation, and the ratification of the company’s independent registered public accounting firm.
At the meeting, stockholders elected one Class II Director, Phillip J. Kardis II, to serve until the 2027 annual meeting and two Class III Directors, Brian P. Reilly and Cynthia B. Walsh, to serve until the 2028 annual meeting. The election results indicated a strong majority in favor of the nominees, with Phillip J. Kardis II receiving over 41 million votes for his election.
Additionally, the non-binding advisory vote on executive compensation was approved with over 40 million votes in favor. This reflects stockholder support for the company’s executive pay practices.
The appointment of Ernst & Young LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified with a significant majority. Nearly 60 million votes were cast in favor of the ratification, demonstrating stockholder confidence in the accounting firm’s role.
The annual meeting had a high turnout, with approximately 75.82% of the common stock entitled to vote being present in person or by proxy. This level of participation underscores the importance stockholders place on the governance of the company. Notably, Chimera has maintained dividend payments for 19 consecutive years, currently offering an attractive 10.64% yield. InvestingPro subscribers can access detailed analysis and 6 additional key insights about CIM’s financial performance and outlook through the comprehensive Pro Research Report, available exclusively on the platform.
The information provided in this article is based on a press release statement from Chimera Investment Corporation.
In other recent news, Chimera Investment Corporation announced its Q1 2025 earnings, reporting an earnings per share (EPS) of $0.41, which fell short of the projected $0.44. However, the company’s revenue significantly exceeded expectations, coming in at $206.5 million against a forecast of $75.97 million. In addition, Chimera declared a second-quarter cash dividend of $0.37 per common share, maintaining its consistent dividend policy. UBS analyst Doug Harter upgraded Chimera’s stock rating from Neutral to Buy, raising the price target to $15.00 due to the company’s better-than-expected book value performance and improved earnings forecasts. Harter highlighted Chimera’s ability to optimize liabilities and free up capital for reinvestment as key factors for the upgrade. The company also completed the acquisition of Palisades Advisory Services, enhancing its service offerings and contributing to its strong revenue performance. UBS noted the potential for Chimera to increase its dividend, which could further boost its price-to-book multiple. These developments indicate Chimera’s strategic focus on asset management and maintaining a resilient financial position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.